Status:
COMPLETED
Evaluation of Swallowing Muscles Using Ultrasonography and Shear Wave Elastography in Patients Receiving Radiotherapy for Nasopharyngeal Carcinoma Diagnosis
Lead Sponsor:
Konya Beyhekim Training and Research Hospital
Collaborating Sponsors:
Selcuk University
Conditions:
Patients Receiving Radiotherapy for Nasopharyngeal Carcinoma Diagnosis
Ultrasonography and Shear Wave Elastography
Eligibility:
All Genders
18-65 years
Brief Summary
The aim of this study is to evaluate the mylohyoid, geniohyoid and digastric muscles in patients with radiotherapy-induced dysphagia due to nasopharynx cancer using ultrasonography and shear wave elas...
Detailed Description
Post-radiotherapy swallowing dysfunction evaluation was carried out using fibreoptic endoscopic evaluation (FEES), ultrasonography of the swallowing muscles, shear wave elastography and swallowing ass...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Patient Group:
- Volunteered for the study.
- Aged 18-65 years.
- Diagnosed with Stage I nasopharynx cancer.
- Completed radiotherapy treatment at least 12 months prior to the study.
- No additional cancer diagnoses.
- No history of chemo-radiotherapy.
- No prior head-neck trauma or surgery.
- No rheumatologic or neuromuscular disorders.
- No pre-existing swallowing disorders.
- Control Group (Healthy Volunteers):
- Control group:
- Aged 18-65 years.
- No history of head and neck cancer.
- No prior neck surgery or trauma.
- No radiotherapy to the head and neck region.
- No rheumatologic or neuromuscular disorders.
- No central haemorrhagic or ischemic disease.
- No pre-existing swallowing disorders.
- Exclusion Criterias:
- Younger than 18 years or older than 65 years.
- Any history of neck interventions (e.g., for cancer metastasis, cervical spine surgery, trauma).
- Presence of systemic conditions potentially causing dysphagia (e.g., neurological, rheumatological, metabolic, or muscular disorders).
- Previous radiotherapy for reasons other than Stage I nasopharynx cancer (in the patient group).
- Any other cancer diagnosis besides Stage I nasopharynx cancer (in the patient group).
Exclusion
Key Trial Info
Start Date :
January 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2023
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT06934837
Start Date
January 1 2023
End Date
June 1 2023
Last Update
April 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Selçuk University Faculty of Medicine Hospital
Konya, Turkey (Türkiye), 42020